Page 28 - 15Diarrhoeaandvomiting
P. 28

Scope and methodology




                           The need for a guideline

                           A number of recommendation and guidelines on the management of gastroenteritis in childhood
                           have been published. 16–22  However, this guideline is unique.
                           Some guidelines have focused on specific subgroups of children, such as those presenting to a
                           hospital setting. This guideline is intended to apply to children younger than 5 years in England
                           and Wales who present to a healthcare professional for advice in any setting. Importantly, it differs
                           from other guidelines in that it was developed using a set of important principles employed for all
                           NICE clinical guidelines. At the outset there was a process of national consultation to determine
                           the key areas of management that should be addressed and to define the exact ‘scope’ of the
                           guideline. Recommendations were based on the best available evidence whenever possible. A
                           systematic and thorough approach was employed to identify relevant research evidence and to
                           evaluate the available studies. For this guideline much of the best evidence is from developing
                           countries and must be interpreted in that light. As there are often important differences in the
                           baseline characteristics of the population, it cannot automatically be assumed that developing
                           country  evidence  is  applicable  to  a  UK  setting.  For  example,  malnutrition  may  often  be  an
                           important clinical feature of gastroenteritis in developing countries, leading to markedly different
                           outcomes than would be observed in a developed country setting. In interpreting developing
                           country evidence, relative effect measures, especially from large meta-analyses, are generally
                           more stable than absolute measures of effect. Variation in baseline characteristics means that
                           evidence based on absolute measures cannot reliably be applied to a developed country setting.
                           However, even relative measures of effect need to be interpreted with a view as to whether
                           the  context  is  sufficiently  similar:  ‘Is  my  patient  so  different  from  those  in  the  trial  that  its
                           results cannot help me make my treatment decision?’  This very much reflected the Guideline
                                                                         23
                           Development Group (GDG) approach in discussing evidence for this guideline from developing
                           country settings.
                           The  GDG  responsible  for  the  guideline  recommendations  was  constituted  so  as  to  include
                           individuals with a wide range of relevant personal and clinical expertise. Various authors have
                                                                                            24
                           commented on the difficulty of implementing guideline recommendations.  In part this may
                           reflect the practical difficulties of following recommendations in a real setting – taking account
                           of practical impediments and professional or parental perceptions or views. The GDG included
                           parents  with  personal  experience  of  caring  for  ill  children.  It  included  doctors  and  nurses
                           working in the community, and in primary, secondary and tertiary healthcare settings. It was
                           supported by a professional ‘technical team’ including information scientists, expert research
                           staff and health economists. External expert advisers were appointed to assist the GDG in its
                           consideration of various complex technical matters. External peer reviewers commented on the
                           guideline during its development. Inevitably, evidence was sometimes limited or non-existent
                           and, in such situations, recommendations were based on GDG consensus opinion. The GDG
                           was able to make recommendations on priority areas for future research. Lastly, there was a
                           process for consultation with ‘stakeholder’ organisations on a draft version of the guideline prior
                           to publication in its final form.


               1.2         Aim of the guideline

                           Clinical  guidelines  have  been  defined  as  ‘systematically  developed  statements  which  assist
                           clinicians and patients in making decisions about appropriate treatment for specific conditions’.
                                                                                                           25
                           The guideline has been developed with the aim of providing guidance on the diagnosis, assessment
                           and management of children younger than 5 years with acute diarrhoea and vomiting caused by
                           gastroenteritis in England and Wales.


               1.3         Areas within the scope of the guideline

                           Population

                           •  Infants and young children from birth up to their fifth birthday presenting to healthcare
                             professionals with acute diarrhoea (lasting 14 days or fewer) due to gastroenteritis, on its
                             own or with vomiting.


                                                                                                            3
   23   24   25   26   27   28   29   30   31   32   33